The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Neoplasms, Hormone-Dependent
Interventions: DRUG: Atamestane|DRUG: Toremifene|DRUG: Letrozole|DRUG: Aromatase inhibition|DRUG: Estrogen receptor blocker|PROCEDURE: Hormone therapy|PROCEDURE: Endocrine therapy|PROCEDURE: Antiestrogen therapy
Sponsor: Intarcia Therapeutics